Advertisement

Drugs & Aging

, Volume 29, Issue 6, pp 437–452 | Cite as

Inappropriate Prescribing

Criteria, Detection and Prevention
  • Marie N. O’ConnorEmail author
  • Paul Gallagher
  • Denis O’Mahony
Review Article

Abstract

Inappropriate prescribing is highly prevalent in older people and is a major healthcare concern because of its association with negative healthcare outcomes including adverse drug events, related morbidity and hospitalization. With changing population demographics resulting in increasing proportions of older people worldwide, improving the quality and safety of prescribing in older people poses a global challenge.

To date a number of different strategies have been used to identify potentially inappropriate prescribing in older people. Over the last two decades, a number of criteria have been published to assist prescribers in detecting inappropriate prescribing, the majority of which have been explicit sets of criteria, though some are implicit. The majority of these prescribing indicators pertain to overprescribing and misprescribing, with only a minority focussing on the underprescribing of indicated medicines. Additional interventions to optimize prescribing in older people include comprehensive geriatric assessment, clinical pharmacist review, and education of prescribers as well as computerized prescribing with clinical decision support systems.

In this review, we describe the inappropriate prescribing detection tools or criteria most frequently cited in the literature and examine their role in preventing inappropriate prescribing and other related healthcare outcomes. We also discuss other measures commonly used in the detection and prevention of inappropriate prescribing in older people and the evidence supporting their use and their application in everyday clinical practice.

Keywords

Comprehensive Geriatric Assessment Inappropriate Medication Inappropriate Prescribe Potential Inappropriate Prescribe Beers Criterion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

Authors Dr Gallagher and Dr O’Mahony developed the inappropriate prescribing tools STOPP and START.

No sources of funding were used to assist in the preparation of this article. The authors have no conflicts of interest that are directly relevant to the content of this article.

References

  1. 1.
    Mangoni AA, Jackson SH. Age related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57: 6–14PubMedCrossRefGoogle Scholar
  2. 2.
    Beers M, Ouslander J, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825–32PubMedCrossRefGoogle Scholar
  3. 3.
    Beers M. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531–6PubMedCrossRefGoogle Scholar
  4. 4.
    McLeod PJ, Huang AR, Tambl RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997 Feb 1; 156 (3): 385–91PubMedGoogle Scholar
  5. 5.
    Naugler CT, Brymer C, Stolee P, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000 Summer; 7 (2): 103–7PubMedGoogle Scholar
  6. 6.
    Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001 Dec 12; 286 (22): 2823–9PubMedCrossRefGoogle Scholar
  7. 7.
    Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec 8–22; 163 (22): 2716–24PubMedCrossRefGoogle Scholar
  8. 8.
    Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007 Aug; 63 (8): 725–31PubMedCrossRefGoogle Scholar
  9. 9.
    Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment): consensus validation. Int J Clin Pharmacol Ther 2008; 46 (2): 72–83PubMedGoogle Scholar
  10. 10.
    Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging 2008; 25 (9): 777–93PubMedCrossRefGoogle Scholar
  11. 11.
    Rognstad S, Brekke M, Fetveit A, et al. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: a modified Delphi study. Scand J Prim Health Care 2009; 27: 153–9PubMedCrossRefGoogle Scholar
  12. 12.
    Holt S, Schmeidl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS List. Dtsch Arztebl Int 2010 Aug; 107 (31–32): 543–51PubMedGoogle Scholar
  13. 13.
    Winit-Watjana W, Sakulrat P, Kespichayawattana J. Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr 2008 Jul–Aug; 47 (1): 35–51PubMedCrossRefGoogle Scholar
  14. 14.
    Rancourt C, Moisan J, Baillargeon L, et al. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr 2004 Oct 15; 4: 9PubMedCrossRefGoogle Scholar
  15. 15.
    The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. JAGS 2012. doi: 10.1111/j.1532–5415.2012. 03923.x [online]. Available from URL: http://www.americangeriatrics.org/files/documents/beers/2012BeersCriteria_JAGS.pdf [Accessed 2012 May 10]
  16. 16.
    Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008 Nov 1; 37 (6): 673–9PubMedCrossRefGoogle Scholar
  17. 17.
    Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home dwelling, elderly patients: a population-based survey. Arch Intern Med 2002 Aug 12–26; 162 (15): 1707–12PubMedCrossRefGoogle Scholar
  18. 18.
    Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005 Mar 16; 293 (11): 1348–58PubMedCrossRefGoogle Scholar
  19. 19.
    van der Hooft CS, Jong GW, Dieleman JP, et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria — a population-based cohort study. Br J Clin Pharmacol 2005 Aug; 60 (2): 137–44PubMedCrossRefGoogle Scholar
  20. 20.
    Onder G, Landi F, Cesari M, et al. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol 2003 Jun; 59 (2): 157–62PubMedGoogle Scholar
  21. 21.
    Laroche M, Charmes J, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007; 63: 177–86PubMedCrossRefGoogle Scholar
  22. 22.
    Corsonello A, Pedone C, Lattanzio F, et al. Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc 2009 Jun; 57 (6): 1007–14PubMedCrossRefGoogle Scholar
  23. 23.
    Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008; 25 (8): 683–92PubMedCrossRefGoogle Scholar
  24. 24.
    Laroche ML, Charmes JP, Bouthier F, et al. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009; 85: 94–7PubMedCrossRefGoogle Scholar
  25. 25.
    Barry PJ, O’Keefe N, O’Connor KA, et al. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the Improved Prescribing in the Elderly Tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 2006 Dec; 31 (6): 617–26PubMedCrossRefGoogle Scholar
  26. 26.
    Cantrill J, Sibbald B, Buetow S. Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility and reliability. Qual Health Care 1998; 7: 130–5PubMedCrossRefGoogle Scholar
  27. 27.
    Gallagher P, Baeyens J-P, Topinkova E, et al. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009 Sep 1; 38 (5): 603–6PubMedCrossRefGoogle Scholar
  28. 28.
    Ryan C, O’Mahony D, Byrne S. Application of STOPP and START criteria: interrater reliability among pharmacists. Ann Pharmacother 2009; 43: 1239–44PubMedCrossRefGoogle Scholar
  29. 29.
    Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 2011; 67 (11): 1175–88PubMedCrossRefGoogle Scholar
  30. 30.
    Liu CL, Peng L, Chen Y, et al. Potentially inappropriate prescribing (IP) for elderly medical inpatients in Taiwan: a hospital-based study. Arch Gerontol Geriatr. Epub 2011 Aug 3Google Scholar
  31. 31.
    Ryan C, O’Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol 2009 Dec; 68 (6): 936–47PubMedCrossRefGoogle Scholar
  32. 32.
    O’Mahony D, Gallagher P, Ryan C, et al. STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age. European Geriatric Medicine 2010; 1 (1): 45–51CrossRefGoogle Scholar
  33. 33.
    Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011 Jun; 89 (6): 845–54PubMedCrossRefGoogle Scholar
  34. 34.
    Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011 Jun 13; 171 (11): 1013–9PubMedCrossRefGoogle Scholar
  35. 35.
    Prevention of adverse drug events (ADEs) in hospitalised older patients [ClinicalTrials.gov identifier NCT01467050]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://www.clinicaltrials.gov [Accessed 2012 Apr 16]
  36. 36.
    Hanlon J, Schmader K, Samsa G, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045–51PubMedCrossRefGoogle Scholar
  37. 37.
    Fitzgerald L, Hanlon J, Shelton PS, et al. Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 1997; 31: 543–8PubMedGoogle Scholar
  38. 38.
    Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004 Jan; 38 (1): 9–14PubMedCrossRefGoogle Scholar
  39. 39.
    Hajjar ER, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005 Sep; 53 (9): 1518–23PubMedCrossRefGoogle Scholar
  40. 40.
    Lund B, Carnahan R, Egge J, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010 Jun; 44: 957–63PubMedCrossRefGoogle Scholar
  41. 41.
    Jeffry S, Ruby CM, Twesky J, et al. Effect of an interdisciplinary team on suboptimal prescribing in a long-term care facility. Consult Pharm 1999; 14: 1386–91Google Scholar
  42. 42.
    Lipton HL, Bero LA, Bird JA, et al. The impact of clinical pharmacists’ consultations on physicians geriatric drug prescribing. A randomized controlled trial. Med Care 1992; 30: 646–58PubMedCrossRefGoogle Scholar
  43. 43.
    Steinman MA, Landefield CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516–23PubMedCrossRefGoogle Scholar
  44. 44.
    Crotty M, Halbert J, Rowett D. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33: 612–7PubMedCrossRefGoogle Scholar
  45. 45.
    Schmader K, Hanlon J, Pieper CF. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116: 394–401PubMedCrossRefGoogle Scholar
  46. 46.
    Strandberg TE, Pitkala K, Berglind S, et al. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomized controlled trial. Am Heart J 2006; 152: 585–92PubMedCrossRefGoogle Scholar
  47. 47.
    Saltvedt I, Spigset O, Ruths S, et al. Patterns of drug prescription in a geriatric evaluation and management unit compared with the general medical wards: a randomised study. Eur J Clin Pharmacol 2005; 61: 921–8PubMedCrossRefGoogle Scholar
  48. 48.
    Spinewine A, Swine C, Dhillon S, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized controlled trial. J Am Geriatr Soc 2007; 55 (5): 658–65PubMedCrossRefGoogle Scholar
  49. 49.
    Spinewine A, Dhillon S, Mallet L, et al. Implementation of ward-based clinical pharmacy services in Belgium-description of the impact on a geriatric unit. Ann Pharmacother 2006; 40 (4): 720–8PubMedCrossRefGoogle Scholar
  50. 50.
    Hanlon J, Weinberger M, Samsa GP. A randomised controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100: 428–37PubMedCrossRefGoogle Scholar
  51. 51.
    Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from hospital to a long-term care facility? Results of a randomized controlled trial. Am J Geriatr Pharmacother 2004; 2: 257–64PubMedCrossRefGoogle Scholar
  52. 52.
    National Service Framework for Older People. Medicines and older people — implementing medications-related aspects of the NSF for older people. London: Department of Health, HMSO, 2001Google Scholar
  53. 53.
    Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging 2012; 29 (6): 495–510PubMedCrossRefGoogle Scholar
  54. 54.
    Bragg E, Warshaw G. ACGME requirements for geriatric medicine curricula in medical specialities: progress made and progress needed. Acad Med 2005; 80: 279–85PubMedCrossRefGoogle Scholar
  55. 55.
    Eleazer G, Doshi R, Wieland D, et al. Geriatric content in medical school curricula: results of a national survey. J Am Geriatr Soc 2005; 53: 136–40PubMedCrossRefGoogle Scholar
  56. 56.
    Lutters M, Harbarth S, Janssens J. Effect of a comprehensive multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc 2004; 52: 112–6PubMedCrossRefGoogle Scholar
  57. 57.
    Pimlott N, Hux J, Wilson L et al. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ 2003; 168: 835–9PubMedGoogle Scholar
  58. 58.
    Stein C, Griffin MR, Taylor JA, et al. Educational program for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized controlled trial. Med Care 2001; (39): 436–45PubMedCrossRefGoogle Scholar
  59. 59.
    Kuperman GJ, Gibson RF. Computer physician order entry: Benefits, costs and issues. Arch Intern Med 2003; 139: 31–9CrossRefGoogle Scholar
  60. 60.
    Kaushal R, Shojania KG, Bates DW. Benefits of computerized physician order entry and clinical decision support systems on medication safety. Arch Intern Med 2003; 163: 1409–16PubMedCrossRefGoogle Scholar
  61. 61.
    Tamblyn R, Huang A, Perreault R. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ 2003; 169: 549–56PubMedGoogle Scholar
  62. 62.
    Peterson JF, Kuperman GJ, Shek C, et al. Guided prescription of psychotropic medications for geriatric outpatients. Arch Intern Med 2005; 165: 802–7PubMedCrossRefGoogle Scholar
  63. 63.
    Gurwitz JH, Field T, Rochon P, et al. Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc 2008; 56: 2225–33PubMedCrossRefGoogle Scholar
  64. 64.
    Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR Risk Score. Arch Intern Med 2010 Jul 12; 170 (13): 1142–8PubMedCrossRefGoogle Scholar
  65. 65.
    O’Connor MN, Gallagher P, Byrne S et al. Adverse drug reactions in older people during hospitalisation: are they predictable? Age Ageing. Epub 2012 Mar 28Google Scholar

Copyright information

© Springer International Publishing AG 2012

Authors and Affiliations

  • Marie N. O’Connor
    • 1
    Email author
  • Paul Gallagher
    • 1
    • 2
  • Denis O’Mahony
    • 1
    • 2
  1. 1.Department of Geriatric MedicineCork University HospitalWiltonIreland
  2. 2.School of MedicineUniversity College CorkIreland

Personalised recommendations